Heated chemo during surgery may extend life for Drug-Resistant ovarian cancer
NCT ID NCT05316181
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a combination of surgery to remove visible tumors plus heated chemotherapy delivered directly into the abdomen can help people with ovarian cancer that has stopped responding to standard platinum-based chemo. About 140 adults with this type of recurrent ovarian cancer will be randomly assigned to receive either surgery plus heated chemo or standard care alone. The main goal is to see if the combination delays cancer growth and improves survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYTOREDUCTIVE SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ewha Womans University Mokdong Hospital
Seoul, South Korea
-
Korea University Anam hospital
Seoul, South Korea
-
Myong Cheol Lim
Goyang-si, Gyeonggi-do, 10408, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Metabolic clues: could your Body's energy use predict ovarian cancer outcomes?
- Can a custom vaccine train the body to fight ovarian cancer?
- Can a 'Smart Bomb' drug outsmart recurrent ovarian cancer?
- Can a targeted drug boost standard ovarian cancer therapy?
- Can heated chemo during surgery help older women with ovarian cancer?
- Can a daily pill keep BRCA-Linked ovarian cancer at bay?